Human primary muscle stem cells regenerate injured urethral sphincter in athymic rats.

human muscle stem cells sphincter injury telemetry urinary incontinence urodynamics

Journal

Animal models and experimental medicine
ISSN: 2576-2095
Titre abrégé: Animal Model Exp Med
Pays: United States
ID NLM: 101726292

Informations de publication

Date de publication:
10 2022
Historique:
received: 05 07 2022
accepted: 26 09 2022
pubmed: 9 10 2022
medline: 1 11 2022
entrez: 8 10 2022
Statut: ppublish

Résumé

The aim of the study was to demonstrate the efficacy of human muscle stem cells (MuSCs) isolated using innovative technology in restoring internal urinary sphincter function in a preclinical animal model. Colonies of pure human MuSCs were obtained from muscle biopsy specimens. Athymic rats were subjected to internal urethral sphincter damage by electrocauterization. Five days after injury, 2 × 10 There was a highly significant improvement in the ability to build up peak pressure as well as a pressure rise in animals that had received muscle stem cells as compared to control (p = 0.007) 3 weeks after the cells had been injected. Only minimal histologic evidence of scarring was observed in treated rats. Primary human muscle stem cells obtained using innovative technology functionally restore internal urethral sphincter function after injury. Translation into use in clinical settings is foreseeable.

Sections du résumé

BACKGROUND
The aim of the study was to demonstrate the efficacy of human muscle stem cells (MuSCs) isolated using innovative technology in restoring internal urinary sphincter function in a preclinical animal model.
METHODS
Colonies of pure human MuSCs were obtained from muscle biopsy specimens. Athymic rats were subjected to internal urethral sphincter damage by electrocauterization. Five days after injury, 2 × 10
RESULTS
There was a highly significant improvement in the ability to build up peak pressure as well as a pressure rise in animals that had received muscle stem cells as compared to control (p = 0.007) 3 weeks after the cells had been injected. Only minimal histologic evidence of scarring was observed in treated rats.
CONCLUSION
Primary human muscle stem cells obtained using innovative technology functionally restore internal urethral sphincter function after injury. Translation into use in clinical settings is foreseeable.

Identifiants

pubmed: 36208013
doi: 10.1002/ame2.12280
pmc: PMC9610153
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-460

Informations de copyright

© 2022 The Authors. Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.

Références

J Urol. 1992 Jul;148(1):183-7
pubmed: 1613867
J Urol. 2021 Feb;205(2):524-531
pubmed: 32909876
Neurourol Urodyn. 2004;23(2):166-71
pubmed: 14983430
Int J Mol Sci. 2021 Apr 12;22(8):
pubmed: 33921532
J Urol. 2000 Nov;164(5):1745-50
pubmed: 11025763
PLoS One. 2010 Aug 19;5(8):e12298
pubmed: 20808873
Animal Model Exp Med. 2022 Oct;5(5):453-460
pubmed: 36208013
Urology. 2018 Jul;117:9-17
pubmed: 29339111
Urology. 2001 Apr;57(4):826-31
pubmed: 11306423
Urology. 2004 Apr;63(4):780-5
pubmed: 15072911
J Urol. 1997 Feb;157(2):704-9
pubmed: 8996402
Organogenesis. 2013 Jul-Sep;9(3):224-33
pubmed: 23917648
Life Sci. 2001 Jul 27;69(10):1193-202
pubmed: 11508351
BJU Int. 2004 Feb;93(3):382-7
pubmed: 14764143
Urol Int. 1997;58(3):153-9
pubmed: 9188136
Cell Transplant. 2012;21(9):2089-98
pubmed: 22236637
BJU Int. 2015 Nov;116(5):823-32
pubmed: 25682883
Neurourol Urodyn. 2017 Feb;36(2):308-315
pubmed: 26879122
Neurourol Urodyn. 2001;20(3):287-95
pubmed: 11385695
J Urol. 2009 Mar;181(3):1444-51
pubmed: 19157444
Int Urogynecol J Pelvic Floor Dysfunct. 2003 Feb;14(1):31-7; discussion 37
pubmed: 12601514
J Clin Invest. 2014 Oct;124(10):4257-65
pubmed: 25157816
Int Urogynecol J Pelvic Floor Dysfunct. 2007 May;18(5):493-7
pubmed: 16900436
Urology. 2006 Aug;68(2):449-54
pubmed: 16904482
Neurourol Urodyn. 2011 Jun;30(5):636-46
pubmed: 21661007
J Urol. 1992 Nov;148(5):1615-20
pubmed: 1433577

Auteurs

Biniam M Bekele (BM)

Muscle Research Unit, Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité, Universitätsmedizin Berlin, Berlin, Germany.
Charité Universitätsmedizin, Berlin, Germany.
Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Berlin Institute of Health at Charité Universitätsmedizin, Belrin, Germany.

Verena Schöwel-Wolf (V)

Muscle Research Unit, Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité, Universitätsmedizin Berlin, Berlin, Germany.
Charité Universitätsmedizin, Berlin, Germany.
Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Berlin Institute of Health at Charité Universitätsmedizin, Belrin, Germany.

Janine Kieshauer (J)

Muscle Research Unit, Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité, Universitätsmedizin Berlin, Berlin, Germany.
Charité Universitätsmedizin, Berlin, Germany.
Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Andreas Marg (A)

Muscle Research Unit, Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité, Universitätsmedizin Berlin, Berlin, Germany.
Charité Universitätsmedizin, Berlin, Germany.
Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.

Andreas Busjahn (A)

HealthTwist GmbH, Berlin, Germany.

Sarah Davis (S)

Charles River Laboratories, Mattawan, Michigan, USA.

Gayle Nugent (G)

Charles River Laboratories, Mattawan, Michigan, USA.

Anne-Karoline Ebert (AK)

Department of Urology and Pediatric Urology, University Hospital Ulm, Ulm, Germany.

Simone Spuler (S)

Muscle Research Unit, Experimental and Clinical Research Center, a cooperation between the Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association and the Charité, Universitätsmedizin Berlin, Berlin, Germany.
Charité Universitätsmedizin, Berlin, Germany.
Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Berlin Institute of Health at Charité Universitätsmedizin, Belrin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH